Of all the communities touched by the COVID-19 pandemic, healthcare professionals (HCPs) are arguably among those most affected. Specialists on the front lines in primary care, critical care, infectious diseases, and pulmonology roles have experienced COVID-19 first hand—often risking their own health and that of their families to help. A new report from Apollo Intelligence provides a barometer on physicians’ sentiments for 2022, and together with other research, frames a wake-up call to medical device and pharma teams in charge of building a brand presence with prescribers.
Checkpoint inhibitor pioneer James P. Allison, who won the 2018 Nobel Prize in Medicine, will helm a new research and innovation hub at The University of Texas MD Anderson Cancer Center that is focused on developing new immunotherapy breakthroughs in oncology.
The Omicron variant of the coronavirus is causing a dramatic rise in cases of croup, a dangerous respiratory condition usually seen in babies and toddlers, new data suggest. Additionally, new research sheds light on how a tuberculosis vaccine might help protect against COVID-19.
With the Omicron surge waning – at least in the United States – there is speculation that the COVID-19 pandemic may be in its end stages, although some experts warn that this could be premature.
President Joe Biden on Feb. 2 announced plans to reduce the death rate from cancer by at least 50 percent over the next 25 years, part of an effort to revive the “Cancer Moonshot” initiative to speed research and make more treatments available.
New research out of Harvard University strongly suggests that infection with the Epstein-Barr virus (EBV) is the leading cause of a debilitating disease of the brain and CNS – multiple sclerosis.
Researchers globally produce hundreds of thousands of studies annually. It can be difficult to know if at some time in the future they will be the foundation for a disease cure or a technology such as CRISPR that revolutionizes medicine. But many are exciting for what they point to or how they spike the imagination. BioSpace reviews 10 of the more compelling research stories of 2021.
A study out of the University of Gothenberg found that good control of blood sugar is important for decreasing the risk of cancer in obesity and type 2 diabetes.
A team of Yale researchers found a key to unlocking the deadly mystery of brain aneurysms in adults.
CMI Media Group has issued the “2021/2022 Media Vitals™ What Healthcare Consumers Want and Need from Life Sciences Manufacturers” report. Media Vitals research, which is conducted by CMI Media Group, is an annual barometer of the wants and needs of the company’s key consumer audiences.